This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boukerche, H. Articles by Fisher, P. B. Search for Related Content PubMed PubMed Citation Articles by Boukerche, H. Articles by Fisher, P. B.

mda-9/Syntenin Regulates the Metastatic Phenotype in Human Melanoma Cells by Activating Nuclear Factor-B

Departments of ¹ Urology, ² Neurosurgery, and ³ Pathology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York

Requests for reprints: Paul B. Fisher, Departments of Pathology and Urology, College of Physicians and Surgeons, Columbia University Medical Center, 630 West 168th Street, BB-1501, New York, NY 10032. Phone: 212-305-3642, -3966; Fax: 212-305-8177; E-mail: pbf1{at}columbia.edu.

mda-9/Syntenin is a scaffolding PDZ domain-containing protein overexpressed in multiple human cancers that functions as a positive regulator of melanoma metastasis. Using a normal immortal human melanocyte cell line and weakly and highly metastatic human melanoma cell lines, we presently show that mda-9/syntenin initiates a signaling cascade that activates nuclear factor-B (NF-B) in human melanoma cells. As a consequence of elevated mda-9/syntenin expression, tumor cell growth and motility, fundamental components of tumor cell invasion and metastatic spread of melanoma cells, are enhanced through focal adhesion kinase (FAK)–induced and p38 mitogen-activated protein kinase (MAPK)–induced activation of NF-B. Inhibiting mda-9/syntenin, using an adenovirus expressing antisense mda-9/syntenin, NF-B, using an adenovirus expressing a mutant superrepressor of IB, or FAK, and using a dominant-negative mutant of FAK (FRNK), blocks melanoma cell migration, anchorage-independent growth, and invasion. Downstream signaling changes mediated by mda-9/syntenin, which include activation of FAK, p38 MAPK, and NF-B, promote induction of membrane-type matrix metalloproteinase-1 that then activates pro-MMP-2–promoting migration and extracellular matrix invasion of melanoma cells. These results highlight the importance of mda-9/syntenin as a key component of melanoma metastasis providing a rational molecular target for potentially intervening in the metastatic process. [Cancer Res 2007;67(4):1812–22]

This article has been cited by other articles:

				H. Boukerche, Z.-z. Su, C. Prevot, D. Sarkar, and P. B. Fisher mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src PNAS, October 14, 2008; 105(41): 15914 - 15919. [Abstract] [Full Text] [PDF]

				D. Sarkar, H. Boukerche, Z.-z. Su, and P. B. Fisher mda-9/Syntenin: More than Just a Simple Adapter Protein When It Comes to Cancer Metastasis Cancer Res., May 1, 2008; 68(9): 3087 - 3093. [Abstract] [Full Text] [PDF]

				J. M. Beekman and P. J. Coffer The ins and outs of syntenin, a multifunctional intracellular adaptor protein J. Cell Sci., May 1, 2008; 121(9): 1349 - 1355. [Abstract] [Full Text] [PDF]